Galectin Therapeutics GALT, the leading developer of therapeutics
that target galectin proteins to treat fibrosis and cancer, announced today
the establishment of a collaborative drug discovery program with Dr. Geert-Jan
Boons' laboratory located in the Complex Carbohydrate Research Center at the
University of Georgia. This program is focused on the discovery of new
carbohydrate molecules that can be used in the therapy of diseases where
galectin proteins play a major role, including cancer and inflammatory and
fibrotic disorders.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Posted In: News
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in